Corporate News     10-Aug-23
Board of Natco Pharma recommends Interim Dividend
Of Rs.7 per share
Natco Pharma announced that the Board of Directors of the Company at its meeting held on 09 August 2023, has recommended a Interim dividend of Rs.7 per share (i.e.350%), subject to the approval of the shareholders.
Previous News
  Sensex, Nifty end lower amid global cues; PSU bank shares slides; VIX rallies 3.86%
 ( Market Commentary - Quick Review 04-Sep-24   15:51 )
  Barometers trade with modest losses; European mkt slides
 ( Market Commentary - Mid-Session 04-Sep-24   13:33 )
  Natco Pharma hits 52-week high as PAT rises 40% YoY in Q4
 ( Hot Pursuit - 28-May-24   10:58 )
  Natco Pharma consolidated net profit rises 40.07% in the March 2024 quarter
 ( Results - Announcements 28-May-24   12:05 )
  Natco Pharma clears USFDA inspection of its Pharmacovigilance compliance
 ( Corporate News - 02-Nov-23   09:05 )
  Natco Pharma Ltd spurts 0.09%, gains for fifth straight session
 ( Hot Pursuit - 25-Jul-23   13:00 )
  Natco Pharma receives warning letter from USFDA for its Kothur unit
 ( Corporate News - 09-Apr-24   10:35 )
  Board of Natco Pharma recommends Third Interim Dividend
 ( Corporate News - 10-Feb-23   10:10 )
  Natco Pharma fixes record date for interim dividend
 ( Market Beat - Reports 09-Aug-22   18:51 )
  Natco Pharma reports consolidated net loss of Rs 50.50 crore in the March 2022 quarter
 ( Results - Announcements 30-May-22   16:51 )
  Natco Pharma receives USFDA tentative approval for Trabectedin for Injection
 ( Corporate News - 17-Aug-22   18:54 )
Other Stories
  GAIL (India) signs MoU with AM Green
  04-Oct-24   19:27
  EaseMyTrip.com resumes bookings to the Maldives
  04-Oct-24   19:25
  BLS completes acquisition of Dubai-based Citizenship Invest
  04-Oct-24   19:23
  Insecticides India launches new maize herbicide 'Torry Super'
  04-Oct-24   19:21
  Landmark Cars receives LoI from Mercedes-Benz India
  04-Oct-24   19:19
  Astra Microwave Products receives affirmation in credit ratings from CRISIL
  04-Oct-24   19:16
  Supreme Petrochem receives affirmation in credit ratings
  04-Oct-24   19:10
  Astec LifeSciences director resigns
  04-Oct-24   19:08
  Board of Gravita India approves change in directorate
  04-Oct-24   19:05
  Board of Gravita India approves fund raising up to Rs 1,000 cr
  04-Oct-24   19:03
Back Top